What is the recommended dosage and treatment protocol for Lisinopril (Angiotensin-Converting Enzyme inhibitor) in patients with hypertension and heart failure?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Lisinopril Dosage and Treatment Protocol for Hypertension and Heart Failure

For patients with hypertension and heart failure, lisinopril should be initiated at 2.5-5.0 mg once daily for heart failure and 10 mg once daily for hypertension, with titration to target doses of 5-20 mg daily for heart failure and 20-40 mg daily for hypertension. 1, 2

Dosing Protocol for Hypertension

Initial Therapy

  • Start with 10 mg once daily for hypertension 1
  • If patient is already on diuretics, start with 5 mg once daily to minimize risk of hypotension 1
  • For patients with renal impairment (creatinine clearance ≤30 mL/min), start with half the usual dose (5 mg) 1

Maintenance and Titration

  • Titrate dose at 2-week intervals based on blood pressure response 2
  • Usual maintenance dose range: 20-40 mg once daily 1
  • Maximum dose: up to 80 mg daily has been used but may not provide additional benefit 1, 3
  • Monitor blood pressure, renal function, and electrolytes 1-2 weeks after each dose increment 2

Dosing Protocol for Heart Failure

Initial Therapy

  • Start with 5 mg once daily when used with diuretics and (usually) digitalis 1, 2
  • For patients with hyponatremia (serum sodium <130 mEq/L), start with 2.5 mg once daily 1
  • For patients with renal impairment (creatinine clearance ≤30 mL/min), start with 2.5 mg once daily 1

Maintenance and Titration

  • Double the dose at not less than 2-week intervals 2
  • Target dose: 5-20 mg once daily, with maximum of 35 mg daily 2
  • The ATLAS trial demonstrated that higher doses (32.5-35 mg daily) were more effective than lower doses (2.5-5 mg daily) in reducing hospitalizations and the combined endpoint of death or hospitalization 3, 2
  • Continue monitoring blood pressure, renal function, and electrolytes throughout treatment 2

Monitoring Protocol

Initial Monitoring

  • Check serum potassium and creatinine 5-7 days after starting treatment 2
  • Recheck every 5-7 days until potassium values are stable 2

Ongoing Monitoring

  • Check blood pressure, renal function, and electrolytes 1-2 weeks after each dose increment 2
  • Follow-up at 3 months after reaching maintenance dose 2
  • Subsequently monitor at 6-month intervals 2

Special Considerations and Precautions

Before Initiating Therapy

  • Review need for and dose of diuretics and vasodilators 2
  • Consider reducing or withholding diuretics for 24 hours before starting lisinopril 2
  • Avoid potassium-sparing diuretics during initiation of therapy 2
  • Avoid NSAIDs and COX-2 inhibitors 2

Management of Common Issues

Hypotension

  • Asymptomatic low blood pressure generally does not require treatment modification 2
  • For symptomatic hypotension, consider reducing doses of diuretics, nitrates, or other vasodilators 2
  • If hypotension persists despite these measures, consider reducing lisinopril dose 2

Renal Function Changes

  • Some increase in blood urea nitrogen, creatinine, and potassium is expected and often doesn't require action 2
  • An increase in creatinine of up to 50% above baseline or to 3 mg/dL (266 μmol/L), whichever is greater, is acceptable 2
  • If greater rises occur, consider stopping concomitant nephrotoxic drugs and reducing diuretic dose if no signs of congestion 2

Cough

  • ACE inhibitor-induced cough rarely requires discontinuation 2
  • If troublesome cough develops and is proven to be due to ACE inhibition, consider substitution with an angiotensin receptor blocker 2

Contraindications

  • Bilateral renal artery stenosis 2
  • History of angioedema with previous ACE inhibitor therapy 2
  • Pregnancy (especially second and third trimesters) 1

Expected Benefits

  • Improved survival and reduced hospitalizations in heart failure patients 2, 3
  • Effective blood pressure control in hypertensive patients 1, 4
  • Improved quality of life and NYHA functional class in heart failure patients 2, 3

Lisinopril offers the advantage of once-daily dosing and does not require biotransformation for pharmacological activity, making it a suitable option for both hypertension and heart failure management 4, 5.

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.